The decision follows a high-level review by the subject expert committee for vaccines, which raised an alarm over the safety ...

GSK (GSK) has agreed to buy US-listed biotech RAPT Therapeutics (US: RAPT) for $58 a share, valuing the company at about $2.2bn (£1.6bn), as it bolsters its respiratory and immunology pipeline.

Finance adviser says although similar discussions had taken place in the past, this time the initiative has progressed further ...

GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK plc (NYSE:GSK) on January 7 and set a price target of $55.60. The same day, GSK plc ...

GSK plc (NYSE:GSK) is included among the 15 Global Dividend Stocks to Diversify Your Portfolio. On December 10, HSBC analyst Rajesh Kumar raised the firm’s price target on GSK plc (NYSE:GSK) to 1,500 ...

The TTP’s growing attacks in Pakistan from sanctuaries in Afghanistan led to serious frictions with Kabul. Attacks by Baloch insurgents became more audacious in 2025. According to the South Asia ...

Clashes between Pakistan and Afghanistan have sparked a trade war that has closed the border and jammed key trade routes for two months. The closure has caused major losses for farmers, traders, and ...

As tensions simmer between Pakistan and Afghanistan, Islamabad is shifting from coercive diplomacy to managed escalation to bring the Taliban to heel. This deterioration is striking, given Islamabad’s ...

As 2025 draws to a close, Pakistan’s domestic political landscape reflects relative stability in civil-military relations. However, this calm is contrasted by deep estrangement and heightened tensions ...

A new Reuters report, based on data from healthcare research firm 3 Axis Advisors, names Pfizer (PFE) and GSK (GSK) among the leading drugmakers seeking to hike U.S. prices of as many as 360 branded ...

GSK plc (NYSE:GSK) is included among the 15 Global Dividend Stocks to Diversify Your Portfolio. On December 10, HSBC analyst Rajesh Kumar raised the firm’s price target on GSK plc (NYSE:GSK) to 1,500 ...